histopathology testing

Digistain LIMITED provides the Digistain Prognostic Score - Breast, an in vitro diagnostic test for professional use that assesses the risk of recurrence in breast cancer patients following surgery. It is UKCA-marked, registered with the MHRA, and operates on routine FFPE tissue sections using optical scan technology and a validated multivariate statistical model. Results are returned within 1-2 days of specimen receipt at their UK laboratory.

Read more

multivariate statistical analysisoptical scan technologyrisk stratification